Aerosol therapy revisited;Les aerosols: Therapeutique en renouveau

Revue de Pneumologie Clinique

Volumn 54, Issue 3, 1998, Pages 125-134

  Diot, P ^a   Mallet, J P ^a   Lemarie E ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Aerosol; Antibiotics; Bronchodilators; Insulin; Morphine

Indexed keywords

ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN; DORNASE ALFA; INSULIN; MORPHINE; NUCLEOTIDE; PROSTACYCLIN; PROTEINASE INHIBITOR;

AEROSOL; ASTHMA; BRONCHUS OBSTRUCTION; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DYSPNEA; GENE THERAPY; INHALATIONAL DRUG ADMINISTRATION; LUNG TRANSPLANTATION; MEDICAL NEBULIZER; METERED DOSE INHALER; PULMONARY HYPERTENSION; REVIEW; HUMAN; LUNG DISEASE;

AEROSOLS; HUMANS; LUNG DISEASES;

EID: 0032115820     PISSN: 00325821     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Diot P., Le Pape A., Becquemin M. H., Besnier J. M., Boissinot E., Bastides R, Benjemaa M., Choutet P., Lemarié E. : Direct Isotopic Assessment of aerosolized pentamidine deposition: influence of nebuliser. Eur. J. Med., 1993, 2, 484-8.
2. Pascal S., Diot P., Lemarié E. : Antibiothérapie par aérosol. Rev. Mal. Respir., 1992, 9, 145-53.
3. Mallet J. P., Diot P., Lemarié E. : La voie inhalée pour l'administration de médicaments à visée systémique. Rev. Mal. Respir., 1997, 14, 257-67.
4. Diot P., Lemarié E. : Aérosols. In : Médecine nucléaire et pneumologie. Diot P., Baulieu J. L., Lemarié E., eds. Springer-Verlag, 1993, 21-3.
5. Chinet T., Huchon G. : La mauvaise utilisation des aérosols-doseurs pressurisés dans le traitement des maladies bronchiques. Fréquence et conséquences cliniques. Ann. Med Interne, 1994, 145, 119-24.
6. Braunstein G. : Les chambres d'inhalation. Rev. Pneumol. Clin., 1991, 47, 200-7
7. Lemarié E., Diot P. : Adrenergic beta agonists and anticholinersics in obstructive lung diseases. J. Aerosol Med., 1997 : 10, 75-83.
8. Recommandations, pour la prise en charge des bronchopneumopathies chroniques obstructives. Rev. Mal. Resp., 1997, 14, 2S11-2S19.
9. Tournier G., Sardet A., Grosskopf C., Baculard A., Delaisi B. : Nouvelles approches pharmacologiques : la rhDNase. Rev. Pneumol. Clin., 1995, 51, 192-9.
10. O'Riordan T. G., Duncan S. R., Burckart G. J., Griffith B. P., Smaldone G. C. , Production of an aerosol of cyclosporine as a prelude to clinical studies. J. Aerosol Med., 1992, 5, 171-7
11. Iacono A. T., Keenan R. J., Duncan S. R., Smaldone G. C., Dauber J. H., Paradis I. L., Ohori N P., Graurich W. F., Burckart G. J., Zeevi A., Delgado E., O'Riordan T. G., Zendarsky M. M., Yousem S. A., Griffith B. P. : Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am. J. Respir. Crit. Care Med., 1996, 153, 1451-5.
12. Gilbert B. E., Wilson S. Z., Garcon N. M., Wyde P. R., Knight V. : Characterization and administration of cyclosporine liposomes as a small-particle aerosol. Transplantation, 1993, 56, 974-7.
13. O'Riordan T. G., Iacono A., Keenan R. J., Duncan S. R., Burckart G. J., Griffith B. P., Smaldone G. C. : Delivery and distribution of aerosolized cvclosporine in lung alloaraft recipients. Am. J. Respir. Crit. Care Med., 1995, 151, 516-21.
14. Zenati M., Duncan A. J., Burckart G. J., Schaper M., Yousem S. A., Griffith B. P., Casarotto D. : Immunosuppression with aerosolized cyclosporine for prevention of lung rejection in a rat model. Eur. J. Cardio-thorac. Surg., 1991, 5, 266-72.
15. Keenan R. J., Duncan A. J., Yousem S. A., Zenati M., Schaper M., Dowling R. D., Alarie Y., Burckart G. J., Griffith B.P. : Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation. Transplantation, 1992 53, 20-5.
16. Dowling R. D., Zenati M., Burckart G. J., Yousem S. A., Schaper M., Simmons R. L., Hardesty R. L., Griffith B.P. : Aerosolized cyclosporine as single-agent immunotherapy in canine lung allografts. Surgery, 1990, 108, 198-205.
17. Keenan R. J., Zeevi A., Iacono A. T., Spichty K. J., Cai Z.-J. J., Youssem S. A., Ohori N. P., Paradis I. L., Kawai A., Griffith B. P. : Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection : correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. Surgery, 1995, 118, 385-91.
18. Higenbottam T. : The place of prostacyclin in the clinical management of primary pulmonary hypertension. Am. Rev. Respir. Dis., 1987, 136, 782-5.
19. Bihari D., Smithies M., Gimson A., Tinker J. : The effects of vasodilatation with prostacyclin on oxygen delivery and uptake in critically ill patients. N. Engl. J. Med., 1987, 317, 397-403.
20. 1 in adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary sas exchange. Am. Rev. Respir. Dis., 1989, 139, 106-10.
21. Rubin L. J., Mendoza J., Hood M., Mcgoon M., Barst R., Williams W. B., Diehl J. H., Crow J., Long W. : Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann. Intern. Med., 1990, 112, 485-91.
22. Barst R. J., Rubin L. J., McGoon M. D., Caldwell E. J., Long W. A., Levy P. S. : Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann. Intern. Med., 1994, 121, 409-15.
23. Barst R. J., Rubin L. J., Long W. A., McGoon M. D., Rich S., Badesch D. B., Groves B. M., Tapson V. F., Bourse R. C., Brundage B. H., Koerner S. K., Langleben D., Keller C. A., Murali S , Uretsky B. F., Clayton L. M. Jöbsis M. M., Blackburn S. D., Shortino D., Crow J. W. : A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl J. Med., 1996, 334, 296-301.
24. Walmrath D., Schneider T., Pilch J., Grimminger F., Seeger W. : Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet, 1993, 342, 961-2
25. Walmrath D., Schneider T., Pilch J., Schermuly R., Grimminger F., Seeger W. : Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am. J. Respir. Crit. Care Med., 1995, 151, 724-30.
26. Olschewski H., Walmrath D., Schermuly R., Ghofrani A., Grimminger F., Seeger W. : Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann. Intern. Med., 1996, 124, 820-4.
27. Selam J. L., Slama G. : Systèmes d'administration d'insuline, possibilités et difficultés. Presse Méd., 1992, 21, 1575-80.
28. Hankiss J. : Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. Br. Med. J., 1982, 284, 1707-8.
29. Pontiroli A. E., Alberetto M., Secchi A., Dossi G., Bosi I., Pozza G. : Insulin given intranasally induces hypoalycaemia in normal and diabetic subjects. Br. Med. J., 1982, 284, 303-6.
30. Moses A. C., Gordon G. S., Carey M. C., Flier J. S. : Insulin administered intranasally as an insulin-bile salt aerosol : effectiveness and reproducibility in normal and diabetic subjects. Diabetes, 1983, 32, 1040-7.
31. Salzman R., Manson J. E., Griffing G. T., Kimmerle R., Ruderman N., McCall A., Stoltz E. I., Mullin C., Small D., Armstrong J., Melby J. C. : Intranasal aerosolized insulin, mixed-meal studies and long-term use in type I diabetes. N. Engl. J. Med., 1985, 312, 1078-84.
32. Frauman A. G., Cooper M. E., Parsons B. J., Jerums G., Louis W. J. : Long-term use of intranasal insulin-dependant diabetic patients. Diabetes Care, 1987, 10, 573-8.
33. El-Etr M., Slama G., Desplanque N. : Preprandial intranasal insulin as adjuvant therapy in the type II diabetics. Lancet, 1987, ii, 1085-6.
34. Lee S. W., Sciarra J. J. : Development of an aerosol dosage form containing insulin. J. Pharm. Sci., 1976, 65, 567-72.
35. Schlüter K. J., Köhler D., Enzman F., Kerp L. : Pulmonary administration of human insulin in volunteers and type I-diabetics. Diabetes, 1984, suppl, 75A.
36. Wigley F. M., Londono J. H., Wood S. H., Shipp J. C., Waldman R. H. : Insulin across respiratory mucosae by aerosol delivery. Diabetes, 1971, 20, 552-6.
37. Laube B. L., Georgopoulos A., Adams G. K. : Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA, 1993, 269, 2106-9.
38. Bellofiore S., Di Maria G. U., Privitera S., Sapienza S., Milic-Emili J., Mistretta A. : Endogenous opioids modulate the increase in ventilatory output and dyspnea during severe acute bronchoconstrition. Am. Rev. Respir. Dis., 1990, 142, 812-6.
39. Kirsch J. L., Muro J. R., Stansbury D. W., Fischer C. E., Monfore R., Light R. W. : Effect of naloxone on maximal exercise performance and control of ventilation in COPD. Chest, 1989, 96, 761-6.
40. Light R. W., Muro J. R., Sato R. I., Stansbury D. W., Fischer C. E., Brown S. E. : Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 1989, 139, 126-33.
41. Eiser N., Luce P., Denman W., West C. : Effect of oral diamorphine on dyspnea in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 1990, 141, A323.
42. Giron A. E., Stansbury D. W., Fischer C. E., Light R. W. : Lack of effect of dextromethorphan on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Eur. Respir. J., 1991, 4, 532-5.
43. Eiser N., Denman W. T., West C., Luce P. : Oral diamorphine : lack of effect on dyspnoea and exercise tolerance in the « pink puffer » syndrome. Eur. Respir. J., 1991, 4, 926-31.
44. Young I. H., Daviskas E., Keena V. A : Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung desease. Thorax, 1989, 44, 387-90.
45. Tooms A., Mckenzie A., Grey H. : Nebulised morphine. Lancet, 1993, 342, 1123-4.
46. Beauford W., Saylor T. T., Stansbury D. W., Avalos K., Light R. W. : Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest, 1993, 104, 175-8
47. Masood A. R., Reed J. W., Thomas S. H. L. : Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax, 1995, 50, 629-34.
48. Harris-Eze A O., Sridhar G., Clemens R. E., Zintel T A., Gallagher C. G., Marcimuk D.D. : Low-dose nebulized morphine does not improve exercise in interstitial lung disease. Am. J. Respir. Crit. Care Med., 1995, 152, 1940-5.
49. Assises nationales de la nébulisation. Propositions de bonnes pratiques de l'aérosolthérapie par nébulisation. 1997, 14, 512-6.